Repurposed drugs: fast to market but caution required

Repurposed drugs: fast to market but caution required

Thanks to increased data availability and advancements in science, the concept of repurposing a pre-existing drug or active pharmaceutical ingredient (API) into your own unique product is becoming a cost-effective proposition for many. Not only this, but the speed of getting to market is drastically increased.

In the downloadable article below, Smithers' experts discuss why a cautious approach will provide greater confidence and reduced costs as you minimize the potential for unknowns and can ensure patient safety, through a program of extractables and leachables (E&L) testing.

Download the article to find out more and get in touch with an expert to see how Smithers can help support your product development.

Download the article below:

Smithers-Repurposed-Drugs-Fast-To-Market-But-Caution-Required

Latest Resources

See all resources